Yıl 2012, Cilt 4 , Sayı 3, Sayfalar 1 - 6 2012-08-01

L-carnitine, L-propionyl carnitine and malondialdehyde levels of pediatric patients with solid tumor

Arzu OKUR [1]


It is known that the production of free O2 radicals and oxidation products have a significant increase in patients with cancer. There are endogeneous protection systems in order to remove free O2 radicals. One of these endogeneous protection system is carnitine. Carnitine has an important role in muscle functions and in obtaining energy from the membranes of body cells. This study aims to investigate the role of L-carnitine, L-propionyl carnitine and malondialdehyde (MDA) in antioxidant mechanism in children recently diagnosed with solid tumor. The study group were consisted from 57 children from 2 children's cancer centers (Gazi University Pediatrics Department and Sami Ulus Pediatrics Hospital) who were recently diagnosed with solid tumor and 45 healthy control. There was no significant difference in free carnitine and L-propionyl carnitine levels between patients with solid tumor and healthy controls. But, MDA levels were significantly higher in children with recently diagnosed solid tumor than in healthy controls.
Solid tumor, L-carnitine, L-propionyl carnitine, malondialdehyde (MDA)
Birincil Dil en
Bölüm Original Articles
Yazarlar

Yazar: Arzu OKUR

Tarihler

Yayımlanma Tarihi : 1 Ağustos 2012

Bibtex @ { jps202253, journal = {Journal of Pediatric Sciences}, issn = {}, eissn = {1309-1247}, address = {}, publisher = {Bilal YILDIZ}, year = {2012}, volume = {4}, pages = {1 - 6}, doi = {10.17334/jps.77916}, title = {L-carnitine, L-propionyl carnitine and malondialdehyde levels of pediatric patients with solid tumor}, key = {cite}, author = {Okur, Arzu} }
APA Okur, A . (2012). L-carnitine, L-propionyl carnitine and malondialdehyde levels of pediatric patients with solid tumor . Journal of Pediatric Sciences , 4 (3) , 1-6 . Retrieved from https://dergipark.org.tr/tr/pub/jps/issue/19087/202253
MLA Okur, A . "L-carnitine, L-propionyl carnitine and malondialdehyde levels of pediatric patients with solid tumor" . Journal of Pediatric Sciences 4 (2012 ): 1-6 <https://dergipark.org.tr/tr/pub/jps/issue/19087/202253>
Chicago Okur, A . "L-carnitine, L-propionyl carnitine and malondialdehyde levels of pediatric patients with solid tumor". Journal of Pediatric Sciences 4 (2012 ): 1-6
RIS TY - JOUR T1 - L-carnitine, L-propionyl carnitine and malondialdehyde levels of pediatric patients with solid tumor AU - Arzu Okur Y1 - 2012 PY - 2012 N1 - DO - T2 - Journal of Pediatric Sciences JF - Journal JO - JOR SP - 1 EP - 6 VL - 4 IS - 3 SN - -1309-1247 M3 - UR - Y2 - 2021 ER -
EndNote %0 Journal of Pediatric Sciences L-carnitine, L-propionyl carnitine and malondialdehyde levels of pediatric patients with solid tumor %A Arzu Okur %T L-carnitine, L-propionyl carnitine and malondialdehyde levels of pediatric patients with solid tumor %D 2012 %J Journal of Pediatric Sciences %P -1309-1247 %V 4 %N 3 %R %U
ISNAD Okur, Arzu . "L-carnitine, L-propionyl carnitine and malondialdehyde levels of pediatric patients with solid tumor". Journal of Pediatric Sciences 4 / 3 (Ağustos 2012): 1-6 .
AMA Okur A . L-carnitine, L-propionyl carnitine and malondialdehyde levels of pediatric patients with solid tumor. Journal of Pediatric Sciences. 2012; 4(3): 1-6.
Vancouver Okur A . L-carnitine, L-propionyl carnitine and malondialdehyde levels of pediatric patients with solid tumor. Journal of Pediatric Sciences. 2012; 4(3): 1-6.
IEEE A. Okur , "L-carnitine, L-propionyl carnitine and malondialdehyde levels of pediatric patients with solid tumor", Journal of Pediatric Sciences, c. 4, sayı. 3, ss. 1-6, Ağu. 2012, doi:10.17334/jps.77916

Makalenin Yazarları